First Time Loading...
C

Celltrion Healthcare Co Ltd
KOSDAQ:091990

Watchlist Manager
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Watchlist
Price: 75 900 KRW -5.6% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Celltrion Healthcare Co Ltd

Wall Street analysts forecast Celltrion Healthcare Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Celltrion Healthcare Co Ltd is 97 444 KRW .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
97 444 KRW
28% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
97 444 KRW
28% Upside
Highest
Price Target
Not Available
Celltrion Healthcare Co Ltd Competitors:
Price Targets
FAGR
Fagron NV
21% Upside
PGC
Paragon Care Ltd
7% Downside
4164
CHC Healthcare Group
26% Upside
SIG
Sigma Healthcare Ltd
13% Downside
FAGR
Fagron NV
21% Upside
PGC
Paragon Care Ltd
7% Downside
4164
CHC Healthcare Group
26% Upside
SIG
Sigma Healthcare Ltd
13% Downside
Y
1298
Yunnan Energy International Co Ltd
206% Upside
C
2289
Charmacy Pharmaceutical Co Ltd
23% Downside
HAEK
Haemato AG
59% Upside
HSIC
Henry Schein Inc
11% Upside

Revenue
Forecast

Revenue Estimate
Celltrion Healthcare Co Ltd

For the last 7 years the compound annual growth rate for Celltrion Healthcare Co Ltd's revenue is 25%. The projected CAGR for the next 3 years is 18%.

25%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Celltrion Healthcare Co Ltd

For the last 7 years the compound annual growth rate for Celltrion Healthcare Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 38%.

11%
Past Growth
38%
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Celltrion Healthcare Co Ltd

For the last 7 years the compound annual growth rate for Celltrion Healthcare Co Ltd's net income is 32%. The projected CAGR for the next 3 years is 42%.

32%
Past Growth
42%
Estimated Growth
Estimates Accuracy
-29%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Celltrion Healthcare Co Ltd's stock price target?
Price Target
97 444 KRW

According to Wall Street analysts, the average 1-year price target for Celltrion Healthcare Co Ltd is 97 444 KRW .

What is Celltrion Healthcare Co Ltd's Revenue forecast?
Projected CAGR
18%

For the last 7 years the compound annual growth rate for Celltrion Healthcare Co Ltd's revenue is 25%. The projected CAGR for the next 3 years is 18%.

What is Celltrion Healthcare Co Ltd's Operating Income forecast?
Projected CAGR
38%

For the last 7 years the compound annual growth rate for Celltrion Healthcare Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 38%.

What is Celltrion Healthcare Co Ltd's Net Income forecast?
Projected CAGR
42%

For the last 7 years the compound annual growth rate for Celltrion Healthcare Co Ltd's net income is 32%. The projected CAGR for the next 3 years is 42%.

ALPHA SPREAD
Join more than 132,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.